Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
ChondroNEXT will prevent progression of Osteoarthritis by preventing joint degeneration.
Stephen Waxman, MD, PhD -
Novel treatment for hypertrophic and keloidal scarring
Christopher G Bunick, MD/PhD -
A new class of selective GSK3B-inhibitors for refractory lymphoid malignancies
Markus Müschen, MD, PhD -
Harnessing p53beta as a medical treatment of skin cancer
Christine Ko, MD -
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
Dianqing (Dan) Wu, PhD -
-
curIOS Therapeutics: mRNA therapies targeting the driver antigens in virus-associated cancers
Jeffrey Ishizuka, MD, DPhil -
Innovative approach to treat ALS using a novel small molecule target
Janghoo Lim, PhD -
Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders
Christian Schlieker, PhD -
Advancing a non-hallucinogenic psychedelic drug combination
Alfred Kaye, MD, PhD